SecSonar.com

Merck & Co., Inc. (MRK)

Merck & Co., Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Merck & Co., Inc. (MRK) is a Drug Manufacturers - General company based in US with a market capitalization of $293.4B. Revenue grew 1.2% year-over-year and the company generated $12.4B in free cash flow. This page tracks MRK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 73K employees · IPO Jan 13, 1978

Valuation

Valuation & price

$112.97 · as of May 13, 2026 · -12.8% vs 52w high

15.5

P/E ratio

Latest-FY diluted EPS

5.58

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$130$104$78.12Jul 25Dec 25Jul 26Jul 7, 25$80.90Jul 9, 25$83.71Jul 11, 25$83.36Jul 15, 25$81.52Jul 17, 25$81.52Jul 21, 25$79.31Jul 23, 25$83.98Jul 25, 25$84.71Jul 29, 25$82.63Jul 31, 25$78.12Aug 4, 25$79.86Aug 6, 25$79.44Aug 11, 25$80.03Aug 13, 25$82.71Aug 15, 25$84.21Aug 19, 25$84.93Aug 21, 25$86.08Aug 25, 25$85.31Aug 27, 25$84.07Aug 29, 25$84.12Sep 3, 25$84.18Sep 5, 25$84.71Sep 9, 25$84.61Sep 11, 25$85.15Sep 16, 25$81.09Sep 18, 25$81.53Sep 22, 25$80.40Sep 24, 25$79.67Sep 26, 25$78.56Sep 30, 25$83.93Oct 2, 25$89.51Oct 6, 25$88.80Oct 8, 25$86.40Oct 10, 25$85.99Oct 14, 25$84.70Oct 16, 25$83.92Oct 21, 25$87.62Oct 23, 25$87.18Oct 27, 25$88.00Oct 29, 25$86.58Oct 31, 25$85.98Nov 4, 25$83.86Nov 6, 25$85.78Nov 10, 25$86.75Nov 12, 25$91.45Nov 14, 25$92.92Nov 18, 25$96.43Nov 20, 25$94.97Nov 25, 25$105.66Nov 28, 25$104.83Dec 2, 25$101.03Dec 4, 25$100.89Dec 8, 25$98.93Dec 10, 25$97.62Dec 12, 25$100.30Dec 16, 25$98.27Dec 18, 25$100.69Dec 22, 25$104.72Dec 24, 25$106.45Dec 29, 25$106.62Jan 2, 26$106.45Jan 6, 26$108.87Jan 8, 26$110.99Jan 12, 26$109.19Jan 14, 26$111.01Jan 16, 26$108.83Jan 21, 26$111.11Jan 23, 26$108.18Jan 27, 26$107.92Jan 29, 26$108.34Feb 2, 26$113.37Feb 4, 26$118.33Feb 9, 26$117.65Feb 11, 26$119.26Feb 13, 26$121.41Feb 18, 26$121.66Feb 20, 26$122.26Feb 24, 26$123.93Feb 26, 26$119.30Mar 2, 26$121.41Mar 4, 26$120.28Mar 6, 26$115.79Mar 10, 26$117.09Mar 12, 26$115.91Mar 17, 26$115.87Mar 19, 26$114.20Mar 23, 26$115.68Mar 25, 26$119.37Mar 27, 26$119.63Mar 31, 26$120.29Apr 2, 26$120.87Apr 7, 26$119.28Apr 9, 26$122.68Apr 13, 26$120.15Apr 15, 26$117.90Apr 17, 26$119.07Apr 22, 26$112.89Apr 24, 26$111.90Apr 28, 26$110.03Apr 30, 26$109.18May 4, 26$113.11May 6, 26$113.56May 8, 26$111.38May 12, 26$112.37May 14, 26$113.41May 18, 26$112.56May 20, 26$113.00May 22, 26$122.41May 28, 26$119.89Jun 1, 26$115.17Jun 3, 26$114.70Jun 5, 26$120.79Jun 9, 26$119.60Jun 11, 26$120.76Jun 15, 26$114.90Jun 17, 26$115.44Jun 22, 26$115.48Jun 24, 26$120.60Jun 26, 26$128.66Jul 2, 26$129.56
$77.6052-week range$129.56
Loading valuation history…

Fundamentals

Key fundamentals

$293.4B

Market cap

1.2%

Revenue growth (YoY)

72.0%

Gross margin

$12.4B

Free cash flow (USD)

$36B

Net debt

-1.2%

Share dilution

2/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$39.8BFY 2017$40.1BFY 2018$42.3BFY 2019$39.1BFY 2020$41.5BFY 2021$48.7BFY 2022$59.3BFY 2023$60.1BFY 2024$64.2BFY 2025$64.9B
$39.8B$64.9B

Free cash flow by year

2016 → 2025

FY 2016$8.8BFY 2017$4.6BFY 2018$8.3BFY 2019$10.0BFY 2020$5.8BFY 2021$9.7BFY 2022$14.7BFY 2023$9.1BFY 2024$18.1BFY 2025$12.4B
$8.8B$12.4B

Gross margin by year

2021 → 2025

FY 202172.0%FY 202270.6%FY 202373.2%FY 202476.3%FY 202572.0%
72.0%72.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 4, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 28, 2026Filing
  • 8-K eventDebt IssuanceMay 22, 2026Filing
  • Quarterly report10-Q FiledMay 4, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing

Questions

Frequently asked questions

What is Merck & Co., Inc.'s market cap?

Merck & Co., Inc. (MRK) has a market capitalization of $293.4B.

What is MRK's P/E ratio?

MRK trades at a price-to-earnings ratio of 15.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is MRK's price-to-book (P/B) ratio?

MRK trades at 5.58 times book value per share.

Are insiders buying MRK stock?

SEC Form 4 filings show no open-market insider buys at Merck & Co., Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - General

AZN

AstraZeneca PLC

$288.5B

NVS

Novartis AG

$287.1B

ABBV

AbbVie Inc.

$382B

AMGN

Amgen Inc.

$180.9B

GILD

Gilead Sciences, Inc.

$167.4B

PFE

Pfizer Inc.

$148.6B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.